NYSE president says the appeal of the public market has ‘never been more alive and well’

NYSE president says the appeal of the public market has ‘never been more alive and well’


Companies are eager to go public but are holding back due to the uncertainty in the market, NYSE President Lynn Martin told CNBC’s Jim Cramer on Monday.

“It’s on pause. The reason it’s on pause is because of all the volatility that you see in the market. But you know, the companies that I talk to, those companies who are private, the public market currency has never been more alive and well,” Martin said in an interview on “Mad Money.”

The number of global IPOs, or initial public offerings, declined 54% in the second quarter year-over-year, according to a report from EY. The Americas region saw the biggest drop with a 73% decrease in deals.

U.S. stocks have seesawed this year as skyrocketing inflation, the Federal Reserve’s interest rate increases and the Russia-Ukraine war have led investors to sell holdings. Wall Street is now looking to the Fed’s meeting this week, which many investors expect will lead to a 75 basis point rate increase.

Martin said that the lull in public listings is indicative of the current market environment, not the companies’ willingness to gain new shareholders.

“They want to use that public market currency to grow their business, invest in R&D, acquire new businesses, take their businesses in directions that they can’t even fathom right now. But they’re not going to do it in a period when there’s tremendous volatility in the market,” she said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill
Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the […]

Read More
As tech stocks soar, executives use exchange funds to diversify wealth without selling
Business

As tech stocks soar, executives use exchange funds to diversify wealth without selling

Yuichiro Chino | Moment | Getty Images For executives and founders who have gotten rich off one stock, sometimes it is possible to have too much of a good thing. While the tech stock boom has meant a windfall for employees at high-flying companies, it’s risky to have too much of your net worth tied […]

Read More
How IMAX crushed other theater stocks in 2025
Business

How IMAX crushed other theater stocks in 2025

General atmosphere during an IMAX private screening for the movie “First Man” at an AMC theater in New York City on Oct. 10, 2018. Lars Niki | Getty Images Entertainment | Getty Images The theatrical industry is in flux — and one stock is rising above the rest. IMAX saw its shares jump more than […]

Read More